共 50 条
- [41] Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron OverloadBLOOD, 2014, 124 (21)Kim, Il HwanJoo, Young DonMoon, Joon HoLim, Sung NamSohn, Sang KyunLee, Gyeong WonLee, Ho SupKwon, Ki YoungKim, Sung HyunPark, Kyung TaeChung, Joo SeopLee, Won SikLee, Sang MinHyun, Myung SooKim, HawkRyoo, Hun-MoBae, Sung Hwa
- [42] Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overloadBLOOD RESEARCH, 2014, 49 (01) : 72 - 73Alavi, SaminSadeghi, ElhamAshenagar, Azin
- [43] Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemiaTRANSFUSION, 2014, 54 (06) : 1542 - 1551Cheong, June-WonKim, Hyeoung-JoonLee, Kyoo-HyungYoon, Sung-SooLee, Jae HoonPark, Hee-SookKim, Ho YoungShim, HyeokSeong, Chu-MyungKim, Chul SooChung, JooseopHyun, Myung SooJo, Deog-YeonJung, Chul WonSohn, Sang KyunYoon, Hwi-JoongKim, Byung SooJoo, Young-DonPark, Chi-YoungMin, Yoo Hong
- [44] Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapyCLINICAL CASE REPORTS, 2015, 3 (11): : 952 - 954Pinto, ValeriaBalocco, ManuelaAmbaglio, IlariaDerchi, GiorgioMalcovati, LucaForni, Gian Luca
- [45] LONG TERM EFFICACY AND SAFETY OF DEFERASIROX IN TRANSFUSION DEPENDENT MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WITH IRON OVERLOAD: RESULTS FROM THE EPIC EXTENSION STUDYHAEMATOLOGICA, 2013, 98 : 179 - 180Gattermann, N.Sanz, G.Finelli, C.Forni, G.Nobile, F.Schmid, M.Vassilieff, D.Guerci-Bresler, A.Ganser, A.El-Ali, A.Martin, NiRose, C.
- [46] OPEN MULTI-CENTER TRIAL EVALUATING THE EFFICACY OF DEFERASIROX THERAPY FOR POSTTRANSFUSION IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, THALASSEMIA, AND OTHER ANEMIASGEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (04): : 7 - 14Savchenko, V. G.Abdulkadyrov, K. M.Maschan, A. A.Smetanina, N. S.Golenkov, A. K.Kokhno, A., VSysoeva, E. P.Savinova, M. T.Shelekhova, T., VFinogenova, N. A.Zubarovskaya, L. S.Kaplanov, K. D.Kravchenko, E. G.Lopatina, E. G.
- [47] Iron overload is a most important adverse effect of long-term transfusion therapy in myelodysplastic syndromeVOX SANGUINIS, 2006, 91 : 227 - 227Cermak, J.Walterova, L.Pisacka, M.
- [48] Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overloadTRANSFUSION, 2015, 55 (07) : 1613 - 1620Kim, Il-HwanMoon, Joon-HoLim, Sung-NamSohn, Sang-KyunKim, Hoon-GuLee, Gyeong-WonKim, Yang-SooLee, Ho-SupKwon, Ki-YoungKim, Sung-HyunPark, Kyung-TaeChung, Joo-SeopLee, Won-SikLee, Sang-MinHyun, Myung-SooKim, HawkRyoo, Hun-MoBae, Sung-HwaJoo, Young-Don
- [49] Cost-effectiveness analysis of oral iron chelation therapy with deferasirox (Exjade®, ICL670) versus infusional chelation therapy with deferoxamine in patients with transfusion-dependent myelodysplasticBLOOD, 2005, 106 (11) : 484B - 485BDelea, TEThomas, SKBaladi, JFPhatak, PD
- [50] Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case reportMEDICINE, 2017, 96 (52)Zou, Dong-MeiRong, Dong-DongZhao, HongSu, LiSun, Wan-Ling